118 related articles for article (PubMed ID: 38266355)
1. MAFF confers vulnerability to cisplatin-based and ionizing radiation treatments by modulating ferroptosis and cell cycle progression in lung adenocarcinoma.
Liang J; Bi G; Huang Y; Zhao G; Sui Q; Zhang H; Bian Y; Yin J; Wang Q; Chen Z; Zhan C
Drug Resist Updat; 2024 Mar; 73():101057. PubMed ID: 38266355
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of Linc00173 increases BCL2 mRNA stability via the miR-1275/PROCA1/ZFP36L2 axis and induces acquired cisplatin resistance of lung adenocarcinoma.
Tao X; Li Y; Fan S; Wu L; Xin J; Su Y; Xian X; Huang Y; Huang R; Fang W; Liu Z
J Exp Clin Cancer Res; 2023 Jan; 42(1):12. PubMed ID: 36627670
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional factor MAZ promotes cisplatin-induced DNA damage repair in lung adenocarcinoma by regulating NEIL3.
Wang T; Zhu X; Wang K; Li J; Hu X; Lin P; Zhang J
Pulm Pharmacol Ther; 2023 Jun; 80():102217. PubMed ID: 37121465
[TBL] [Abstract][Full Text] [Related]
4. Hsa_circ_0070440 promotes lung adenocarcinoma progression by SLC7A11-mediated-ferroptosis.
Zhao Y; Cui Q; Shen J; Shen W; Weng Y
Histol Histopathol; 2023 Dec; 38(12):1429-1441. PubMed ID: 36852950
[TBL] [Abstract][Full Text] [Related]
5. Golgi Phosphoprotein 3 Confers Radioresistance via Stabilizing EGFR in Lung Adenocarcinoma.
Chen G; Kong P; Yang M; Hu W; Prise KM; Yu KN; Cui S; Qin F; Meng G; Almahi WA; Nie L; Han W
Int J Radiat Oncol Biol Phys; 2022 Apr; 112(5):1216-1228. PubMed ID: 34838866
[TBL] [Abstract][Full Text] [Related]
6. Let-7c-5p Represses Cisplatin Resistance of Lung Adenocarcinoma Cells by Targeting CDC25A.
Huang L; Lou K; Wang K; Liang L; Chen Y; Zhang J
Appl Biochem Biotechnol; 2023 Mar; 195(3):1644-1655. PubMed ID: 36355336
[TBL] [Abstract][Full Text] [Related]
7.
Jiang F; Shen Q; Zhang F; Fu J; Hu L; Wang J; Zhou H; Chen J; Wang Y
DNA Cell Biol; 2022 Jun; 41(6):631-640. PubMed ID: 35612423
[TBL] [Abstract][Full Text] [Related]
8. LncRNA ITGB2-AS1 promotes cisplatin resistance of non-small cell lung cancer by inhibiting ferroptosis via activating the FOSL2/NAMPT axis.
Chen H; Wang L; Liu J; Wan Z; Zhou L; Liao H; Wan R
Cancer Biol Ther; 2023 Dec; 24(1):2223377. PubMed ID: 37370246
[TBL] [Abstract][Full Text] [Related]
9. Dipeptidase‑2 is a prognostic marker in lung adenocarcinoma that is correlated with its sensitivity to cisplatin.
Wang Y; Zhang T; Du H; Yang M; Xie G; Liu T; Deng S; Yuan W; He S; Wu D; Xu Y
Oncol Rep; 2023 Aug; 50(2):. PubMed ID: 37449493
[TBL] [Abstract][Full Text] [Related]
10. Super-enhancer mediated upregulation of MYEOV suppresses ferroptosis in lung adenocarcinoma.
Luo S; Luo Y; Wang Z; Yin H; Wu Q; Du X; Xie X
Cancer Lett; 2024 May; 589():216811. PubMed ID: 38490328
[TBL] [Abstract][Full Text] [Related]
11. Endogenous glutamate determines ferroptosis sensitivity via ADCY10-dependent YAP suppression in lung adenocarcinoma.
Zhang X; Yu K; Ma L; Qian Z; Tian X; Miao Y; Niu Y; Xu X; Guo S; Yang Y; Wang Z; Xue X; Gu C; Fang W; Sun J; Yu Y; Wang J
Theranostics; 2021; 11(12):5650-5674. PubMed ID: 33897873
[No Abstract] [Full Text] [Related]
12. MafF Is an Antiviral Host Factor That Suppresses Transcription from Hepatitis B Virus Core Promoter.
Ibrahim MK; Abdelhafez TH; Takeuchi JS; Wakae K; Sugiyama M; Tsuge M; Ito M; Watashi K; El Kassas M; Kato T; Murayama A; Suzuki T; Chayama K; Shimotohno K; Muramatsu M; Aly HH; Wakita T
J Virol; 2021 Jul; 95(15):e0076721. PubMed ID: 33980595
[TBL] [Abstract][Full Text] [Related]
13. Propofol decreases cisplatin resistance of non-small cell lung cancer by inducing GPX4-mediated ferroptosis through the miR-744-5p/miR-615-3p axis.
Han B; Liu Y; Zhang Q; Liang L
J Proteomics; 2023 Mar; 274():104777. PubMed ID: 36427803
[TBL] [Abstract][Full Text] [Related]
14. LncRNA HOXA11-AS drives cisplatin resistance of human LUAD cells via modulating miR-454-3p/Stat3.
Zhao X; Li X; Zhou L; Ni J; Yan W; Ma R; Wu J; Feng J; Chen P
Cancer Sci; 2018 Oct; 109(10):3068-3079. PubMed ID: 30099826
[TBL] [Abstract][Full Text] [Related]
15. Regulation of Ferroptosis in Lung Adenocarcinoma.
Wei X; Li X; Hu S; Cheng J; Cai R
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834062
[TBL] [Abstract][Full Text] [Related]
16. SLCO4A1-AS1 promotes cell growth and induces resistance in lung adenocarcinoma by modulating miR-4701-5p/NFE2L1 axis to activate WNT pathway.
Wei Y; Wei L; Li J; Ma Z; Zhang Q; Han Z; Li S
Cancer Med; 2020 Oct; 9(19):7205-7217. PubMed ID: 32762035
[TBL] [Abstract][Full Text] [Related]
17. Hsa-miR-503-5p regulates CTDSPL to accelerate cisplatin resistance and angiogenesis of lung adenocarcinoma cells.
Han J; Wang Y
Chem Biol Drug Des; 2023 Oct; 102(4):749-762. PubMed ID: 37341065
[TBL] [Abstract][Full Text] [Related]
18. HOXB13 networking with ABCG1/EZH2/Slug mediates metastasis and confers resistance to cisplatin in lung adenocarcinoma patients.
Zhan J; Wang P; Li S; Song J; He H; Wang Y; Liu Z; Wang F; Bai H; Fang W; Du Q; Ye M; Chang Z; Wang J; Zhang H
Theranostics; 2019; 9(7):2084-2099. PubMed ID: 31037158
[No Abstract] [Full Text] [Related]
19. [Mechanism of miR-186-5p Regulating PRKAA2 to Promote Ferroptosis
in Lung Adenocarcinoma Cells].
Liu L; Guan X; Zhao Y; Wang X; Yin C; Liu Q; Li H
Zhongguo Fei Ai Za Zhi; 2023 Nov; 26(11):813-821. PubMed ID: 38061883
[TBL] [Abstract][Full Text] [Related]
20. Effects of MicroRNA-195-5p on Biological Behaviors and Radiosensitivity of Lung Adenocarcinoma Cells via Targeting HOXA10.
Yuan C; Bai R; Gao Y; Jiang X; Li S; Sun W; Li Y; Huang Z; Gong Y; Xie C
Oxid Med Cell Longev; 2021; 2021():4522210. PubMed ID: 34925694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
